{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T12:39:55Z","timestamp":1794659995019,"version":"4.9.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007030","name":"Les Turner ALS Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013013","name":"Target ALS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG078713"],"award-info":[{"award-number":["R01AG078713"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003194","name":"New York Stem Cell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41593-026-02300-5","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:02:59Z","timestamp":1778749379000},"page":"1735-1748","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Integrated single-cell and spatial transcriptomic profiling in ALS uncovers peripheral-to-central immune infiltration and reprogramming"],"prefix":"10.1038","volume":"29","author":[{"given":"Ziyang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7569-0470","authenticated-orcid":false,"given":"Lynn","family":"van Olst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Alessandrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6634-934X","authenticated-orcid":false,"given":"Matthew","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5501-2162","authenticated-orcid":false,"given":"Jake","family":"Boles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9126-6239","authenticated-orcid":false,"given":"Anait","family":"Nalbandian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne V.","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8629-3152","authenticated-orcid":false,"given":"Nate","family":"Shepard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Kaspi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3449-645X","authenticated-orcid":false,"given":"Angeli","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Kuruvilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Piehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8116-3685","authenticated-orcid":false,"given":"Abhirami","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2747-6298","authenticated-orcid":false,"given":"Stanley","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8342-8616","authenticated-orcid":false,"given":"Evangelos","family":"Kiskinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0481-9657","authenticated-orcid":false,"given":"David","family":"Gate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"2300_CR1","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman, E. L. et al. Amyotrophic lateral sclerosis. Lancet 400, 1363\u20131380 (2022).","journal-title":"Lancet"},{"key":"2300_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1474-4422(18)30394-6","volume":"18","author":"DR Beers","year":"2019","unstructured":"Beers, D. R. & Appel, S. H. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol. 18, 211\u2013220 (2019).","journal-title":"Lancet Neurol."},{"key":"2300_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ana.10805","volume":"55","author":"JS Henkel","year":"2004","unstructured":"Henkel, J. S. et al. Presence of dendritic cells, MCP-1, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol. 55, 221\u2013235 (2004).","journal-title":"Ann. Neurol."},{"key":"2300_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00005072-199105000-00008","volume":"50","author":"PD Kushner","year":"1991","unstructured":"Kushner, P. D., Stephenson, D. T. & Wright, S. Reactive astrogliosis is widespread in the subcortical white matter of amyotrophic lateral sclerosis brain. J. Neuropathol. Exp. Neurol. 50, 263\u2013277 (1991).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2300_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0022-510X(96)00073-1","volume":"139","author":"D Schiffer","year":"1996","unstructured":"Schiffer, D., Cordera, S., Cavalla, P. & Migheli, A. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. J. Neurol. Sci. 139, 27\u201333 (1996).","journal-title":"J. Neurol. Sci."},{"key":"2300_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/archneur.1993.00540010026013","volume":"50","author":"JI Engelhardt","year":"1993","unstructured":"Engelhardt, J. I., Tajti, J. & Appel, S. H. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch. Neurol. 50, 30\u201336 (1993).","journal-title":"Arch. Neurol."},{"key":"2300_CR7","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1126\/science.aaf1064","volume":"351","author":"JG O\u2019Rourke","year":"2016","unstructured":"O\u2019Rourke, J. G. et al. C9orf72 is required for proper macrophage and microglial function in mice. Science 351, 1324\u20131329 (2016).","journal-title":"Science"},{"key":"2300_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf6038","volume":"8","author":"A Burberry","year":"2016","unstructured":"Burberry, A. et al. Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci. Transl. Med. 8, 347ra393 (2016).","journal-title":"Sci. Transl. Med."},{"key":"2300_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1050984","volume":"13","author":"W Sheng","year":"2022","unstructured":"Sheng, W., Ji, G. & Zhang, L. Role of macrophage scavenger receptor MSR1 in the progression of non-alcoholic steatohepatitis. Front. Immunol. 13, 1050984 (2022).","journal-title":"Front. Immunol."},{"key":"2300_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1012002","volume":"13","author":"J Gudgeon","year":"2022","unstructured":"Gudgeon, J., Marin-Rubio, J. L. & Trost, M. The role of macrophage scavenger receptor 1 (MSR1) in inflammatory disorders and cancer. Front. Immunol. 13, 1012002 (2022).","journal-title":"Front. Immunol."},{"key":"2300_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23168885","volume":"23","author":"E Harmon","year":"2022","unstructured":"Harmon, E. et al. Increased expression of interferon-induced transmembrane 3 (IFITM3) in stroke and other inflammatory conditions in the brain. Int. J. Mol. Sci. 23, 8885 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2300_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri3344","volume":"13","author":"MS Diamond","year":"2013","unstructured":"Diamond, M. S. & Farzan, M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 13, 46\u201357 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"2300_CR13","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.bbrc.2006.02.051","volume":"342","author":"IL Goldknopf","year":"2006","unstructured":"Goldknopf, I. L. et al. Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson\u2019s disease. Biochem. Biophys. Res. Commun. 342, 1034\u20131039 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2300_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1600-0404.1991.tb04656.x","volume":"83","author":"S Apostolski","year":"1991","unstructured":"Apostolski, S. et al. Serum and CSF immunological findings in ALS. Acta Neurol. Scand. 83, 96\u201398 (1991).","journal-title":"Acta Neurol. Scand."},{"key":"2300_CR15","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/jnnp.57.7.859","volume":"57","author":"Y Tsuboi","year":"1994","unstructured":"Tsuboi, Y. & Yamada, T. Increased concentration of C4d complement protein in CSF in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 57, 859\u2013861 (1994).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2300_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1600-0404.1985.tb01548.x","volume":"72","author":"P Annunziata","year":"1985","unstructured":"Annunziata, P. & Volpi, N. High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients. Acta Neurol. Scand. 72, 61\u201364 (1985).","journal-title":"Acta Neurol. Scand."},{"key":"2300_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0538-2","volume":"13","author":"N Bahia El Idrissi","year":"2016","unstructured":"Bahia El Idrissi, N. et al. Complement activation at the motor end-plates in amyotrophic lateral sclerosis. J. Neuroinflammation 13, 72 (2016).","journal-title":"J. Neuroinflammation"},{"key":"2300_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","volume":"1","author":"JW Schoggins","year":"2011","unstructured":"Schoggins, J. W. & Rice, C. M. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1, 519\u2013525 (2011).","journal-title":"Curr. Opin. Virol."},{"key":"2300_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111388","volume":"27","author":"W Yang","year":"2024","unstructured":"Yang, W. et al. Blocking CCL3-mediated neutrophil recruitment into the brain alleviates immunopathology following severe enterovirus 71 infection. iScience 27, 111388 (2024).","journal-title":"iScience"},{"key":"2300_CR20","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/cdd.2015.176","volume":"23","author":"F Martin-Sanchez","year":"2016","unstructured":"Martin-Sanchez, F. et al. Inflammasome-dependent IL-1\u03b2 release depends upon membrane permeabilisation. Cell Death Differ. 23, 1219\u20131231 (2016).","journal-title":"Cell Death Differ."},{"key":"2300_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate, D. et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature 577, 399\u2013404 (2020).","journal-title":"Nature"},{"key":"2300_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00423-w","volume":"16","author":"H Oh","year":"2021","unstructured":"Oh, H. et al. Methods to investigate intrathecal adaptive immunity in neurodegeneration. Mol. Neurodegener. 16, 3 (2021).","journal-title":"Mol. Neurodegener."},{"key":"2300_CR23","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1016\/j.cell.2022.11.019","volume":"185","author":"N Piehl","year":"2022","unstructured":"Piehl, N. et al. Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment. Cell 185, 5028\u20135039 (2022).","journal-title":"Cell"},{"key":"2300_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-017-0379-9","volume":"17","author":"E Rosati","year":"2017","unstructured":"Rosati, E. et al. Overview of methodologies for T-cell receptor repertoire analysis. BMC Biotechnol. 17, 61 (2017).","journal-title":"BMC Biotechnol."},{"key":"2300_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41593-022-01205-3","volume":"26","author":"J Humphrey","year":"2023","unstructured":"Humphrey, J. et al. Integrative transcriptomic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes. Nat. Neurosci. 26, 150\u2013162 (2023).","journal-title":"Nat. Neurosci."},{"key":"2300_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16772-5","volume":"12","author":"R Kabiljo","year":"2022","unstructured":"Kabiljo, R., Iacoangeli, A., Al-Chalabi, A. & Rosenzweig, I. Amyotrophic lateral sclerosis and cerebellum. Sci. Rep. 12, 12586 (2022).","journal-title":"Sci. Rep."},{"key":"2300_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3109\/21678421.2013.812661","volume":"14","author":"T Prell","year":"2013","unstructured":"Prell, T. & Grosskreutz, J. The involvement of the cerebellum in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 14, 507\u2013515 (2013).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"2300_CR28","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41422-018-0053-3","volume":"28","author":"X Fan","year":"2018","unstructured":"Fan, X. et al. Spatial transcriptomic survey of human embryonic cerebral cortex by single-cell RNA-seq analysis. Cell Res. 28, 730\u2013745 (2018).","journal-title":"Cell Res."},{"key":"2300_CR29","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1016\/j.cell.2023.08.037","volume":"186","author":"N Sun","year":"2023","unstructured":"Sun, N. et al. Human microglial state dynamics in Alzheimer\u2019s disease progression. Cell 186, 4386\u20134403 (2023).","journal-title":"Cell"},{"key":"2300_CR30","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1016\/j.cell.2024.02.031","volume":"187","author":"SS Pineda","year":"2024","unstructured":"Pineda, S. S. et al. Single-cell dissection of the human motor and prefrontal cortices in ALS and FTLD. Cell 187, 1971\u20131989 (2024).","journal-title":"Cell"},{"key":"2300_CR31","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1016\/j.neuron.2023.10.035","volume":"111","author":"O Gautier","year":"2023","unstructured":"Gautier, O. et al. Challenges of profiling motor neuron transcriptomes from human spinal cord. Neuron 111, 3739\u20133741 (2023).","journal-title":"Neuron"},{"key":"2300_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2023.01.007","volume":"111","author":"A Yadav","year":"2023","unstructured":"Yadav, A. et al. A cellular taxonomy of the adult human spinal cord. Neuron 111, 328\u2013344 (2023).","journal-title":"Neuron"},{"key":"2300_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1136\/jnnp-2017-317138","volume":"89","author":"P Steinacker","year":"2018","unstructured":"Steinacker, P. et al. Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression. J. Neurol. Neurosurg. Psychiatry 89, 239\u2013247 (2018).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2300_CR34","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1091\/mbc.E14-05-1005","volume":"26","author":"S Maxeiner","year":"2015","unstructured":"Maxeiner, S. et al. Crucial role for the LSP1-myosin1e bimolecular complex in the regulation of Fc\u03b3 receptor-driven phagocytosis. Mol. Biol. Cell 26, 1652\u20131664 (2015).","journal-title":"Mol. Biol. Cell"},{"key":"2300_CR35","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","volume":"84","author":"CH Lu","year":"2015","unstructured":"Lu, C. H. et al. Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis. Neurology 84, 2247\u20132257 (2015).","journal-title":"Neurology"},{"key":"2300_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41593-023-01496-0","volume":"27","author":"J Lopez-Erauskin","year":"2024","unstructured":"Lopez-Erauskin, J. et al. Stathmin-2 loss leads to neurofilament-dependent axonal collapse driving motor and sensory denervation. Nat. Neurosci. 27, 34\u201347 (2024).","journal-title":"Nat. Neurosci."},{"key":"2300_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41593-018-0300-4","volume":"22","author":"JR Klim","year":"2019","unstructured":"Klim, J. R. et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 22, 167\u2013179 (2019).","journal-title":"Nat. Neurosci."},{"key":"2300_CR38","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1126\/science.abq5622","volume":"379","author":"MW Baughn","year":"2023","unstructured":"Baughn, M. W. et al. Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies. Science 379, 1140\u20131149 (2023).","journal-title":"Science"},{"key":"2300_CR39","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.1172\/JCI139741","volume":"130","author":"M Prudencio","year":"2020","unstructured":"Prudencio, M. et al. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J. Clin. Invest. 130, 6080\u20136092 (2020).","journal-title":"J. Clin. Invest."},{"key":"2300_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41593-018-0293-z","volume":"22","author":"Z Melamed","year":"2019","unstructured":"Melamed, Z. et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 22, 180\u2013190 (2019).","journal-title":"Nat. Neurosci."},{"key":"2300_CR41","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41587-021-01139-4","volume":"40","author":"V Kleshchevnikov","year":"2022","unstructured":"Kleshchevnikov, V. et al. Cell2location maps fine-grained cell types in spatial transcriptomics. Nat. Biotechnol. 40, 661\u2013671 (2022).","journal-title":"Nat. Biotechnol."},{"key":"2300_CR42","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","volume":"131","author":"B Stevens","year":"2007","unstructured":"Stevens, B. et al. The classical complement cascade mediates CNS synapse elimination. Cell 131, 1164\u20131178 (2007).","journal-title":"Cell"},{"key":"2300_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11410-x","volume":"7","author":"SL Peterson","year":"2017","unstructured":"Peterson, S. L., Nguyen, H. X., Mendez, O. A. & Anderson, A. J. Complement protein C3 suppresses axon growth and promotes neuron loss. Sci. Rep. 7, 12904 (2017).","journal-title":"Sci. Rep."},{"key":"2300_CR44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0169-328X(92)90017-6","volume":"14","author":"DG Walker","year":"1992","unstructured":"Walker, D. G. & McGeer, P. L. Complement gene expression in human brain: comparison between normal and Alzheimer disease cases. Brain Res. Mol. Brain Res. 14, 109\u2013116 (1992).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"2300_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106376","volume":"183","author":"L Ren","year":"2022","unstructured":"Ren, L. et al. Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis. Pharmacol. Res. 183, 106376 (2022).","journal-title":"Pharmacol. Res."},{"key":"2300_CR46","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130\u2013133 (2006).","journal-title":"Science"},{"key":"2300_CR47","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai, T. et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602\u2013611 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2300_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00525-z","volume":"17","author":"P Masrori","year":"2022","unstructured":"Masrori, P., Beckers, J., Gossye, H. & Van Damme, P. The role of inflammation in neurodegeneration: novel insights into the role of the immune system in C9orf72 HRE-mediated ALS\/FTD. Mol. Neurodegener. 17, 22 (2022).","journal-title":"Mol. Neurodegener."},{"key":"2300_CR49","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00401-013-1199-1","volume":"126","author":"VV Belzil","year":"2013","unstructured":"Belzil, V. V. et al. Reduced C9orf72 gene expression in c9FTD\/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol. 126, 895\u2013905 (2013).","journal-title":"Acta Neuropathol."},{"key":"2300_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/srep23204","volume":"6","author":"A Atanasio","year":"2016","unstructured":"Atanasio, A. et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci. Rep. 6, 23204 (2016).","journal-title":"Sci. Rep."},{"key":"2300_CR51","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.2147\/JIR.S298307","volume":"14","author":"AL Kjaeldgaard","year":"2021","unstructured":"Kjaeldgaard, A. L. et al. Complement profiles in patients with amyotrophic lateral sclerosis: a prospective observational cohort study. J. Inflamm. Res. 14, 1043\u20131053 (2021).","journal-title":"J. Inflamm. Res."},{"key":"2300_CR52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jneuroim.2014.09.005","volume":"276","author":"S Mantovani","year":"2014","unstructured":"Mantovani, S. et al. Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood. J. Neuroimmunol. 276, 213\u2013218 (2014).","journal-title":"J. Neuroimmunol."},{"key":"2300_CR53","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jhep.2021.12.012","volume":"76","author":"O Govaere","year":"2022","unstructured":"Govaere, O. et al. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease. J. Hepatol. 76, 1001\u20131012 (2022).","journal-title":"J. Hepatol."},{"key":"2300_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32587-4","volume":"13","author":"M Clement","year":"2022","unstructured":"Clement, M. et al. IFITM3 restricts virus-induced inflammatory cytokine production by limiting Nogo-B mediated TLR responses. Nat. Commun. 13, 5294 (2022).","journal-title":"Nat. Commun."},{"key":"2300_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102741","volume":"299","author":"M Gomez-Herranz","year":"2023","unstructured":"Gomez-Herranz, M., Taylor, J. & Sloan, R. D. IFITM proteins: understanding their diverse roles in viral infection, cancer, and immunity. J. Biol. Chem. 299, 102741 (2023).","journal-title":"J. Biol. Chem."},{"key":"2300_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03327-w","volume":"21","author":"T Itou","year":"2024","unstructured":"Itou, T. et al. Th17 and effector CD8 T cells relate to disease progression in amyotrophic lateral sclerosis: a case control study. J. Neuroinflammation 21, 331 (2024).","journal-title":"J. Neuroinflammation"},{"key":"2300_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab157","volume":"3","author":"L Rolfes","year":"2021","unstructured":"Rolfes, L. et al. Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation. Brain Commun. 3, fcab157 (2021).","journal-title":"Brain Commun."},{"key":"2300_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34526-9","volume":"13","author":"S Yazdani","year":"2022","unstructured":"Yazdani, S. et al. T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression. Nat. Commun. 13, 6733 (2022).","journal-title":"Nat. Commun."},{"key":"2300_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae428","volume":"6","author":"HJ Kim","year":"2024","unstructured":"Kim, H. J. et al. Single-cell analysis reveals expanded CD8+ GZMKhigh T cells in CSF and shared peripheral clones in sporadic amyotrophic lateral sclerosis. Brain Commun. 6, fcae428 (2024).","journal-title":"Brain Commun."},{"key":"2300_CR60","doi-asserted-by":"crossref","unstructured":"Tuddenham, J. F. et al. Single-cell transcriptomic landscape of the neuroimmune compartment in amyotrophic lateral sclerosis brain and spinal cord. Acta Neuropathol. 150, 10 (2025).","DOI":"10.1007\/s00401-025-02913-3"},{"key":"2300_CR61","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41586-022-04844-5","volume":"606","author":"L Campisi","year":"2022","unstructured":"Campisi, L. et al. Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4. Nature 606, 945\u2013952 (2022).","journal-title":"Nature"},{"key":"2300_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-023-03255-x","volume":"23","author":"T Piccoli","year":"2023","unstructured":"Piccoli, T. et al. Role of the immune system in amyotrophic lateral sclerosis. Analysis of the natural killer cells and other circulating lymphocytes in a cohort of ALS patients. BMC Neurol. 23, 222 (2023).","journal-title":"BMC Neurol."},{"key":"2300_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15644-8","volume":"11","author":"S Garofalo","year":"2020","unstructured":"Garofalo, S. et al. Natural killer cells modulate motor neuron-immune cell cross talk in models of amyotrophic lateral sclerosis. Nat. Commun. 11, 1773 (2020).","journal-title":"Nat. Commun."},{"key":"2300_CR64","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147129","volume":"6","author":"BJ Murdock","year":"2021","unstructured":"Murdock, B. J. et al. NK cells associate with ALS in a sex- and age-dependent manner. JCI Insight 6, e147129 (2021).","journal-title":"JCI Insight"},{"key":"2300_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10488-7","volume":"7","author":"AM D\u2019Erchia","year":"2017","unstructured":"D\u2019Erchia, A. M. et al. Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS. Sci. Rep. 7, 10046 (2017).","journal-title":"Sci. Rep."},{"key":"2300_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00393","volume":"11","author":"BA Loving","year":"2020","unstructured":"Loving, B. A. & Bruce, K. D. Lipid and lipoprotein metabolism in microglia. Front. Physiol. 11, 393 (2020).","journal-title":"Front. Physiol."},{"key":"2300_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-023-00289-z","volume":"43","author":"S Yamamoto","year":"2023","unstructured":"Yamamoto, S. & Masuda, T. Lipid in microglial biology\u2014from material to mediator. Inflamm. Regen. 43, 38 (2023).","journal-title":"Inflamm. Regen."},{"key":"2300_CR68","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.nbd.2011.01.002","volume":"42","author":"M Sta","year":"2011","unstructured":"Sta, M. et al. Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation. Neurobiol. Dis. 42, 211\u2013220 (2011).","journal-title":"Neurobiol. Dis."},{"key":"2300_CR69","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.neuron.2022.02.011","volume":"110","author":"I Guerra San Juan","year":"2022","unstructured":"Guerra San Juan, I. et al. Loss of mouse Stmn2 function causes motor neuropathy. Neuron 110, 1671\u20131688 (2022).","journal-title":"Neuron"},{"key":"2300_CR70","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","volume":"603","author":"XR Ma","year":"2022","unstructured":"Ma, X. R. et al. TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature 603, 124\u2013130 (2022).","journal-title":"Nature"},{"key":"2300_CR71","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41591-023-02788-5","volume":"30","author":"KE Irwin","year":"2024","unstructured":"Irwin, K. E. et al. A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS\u2013FTD. Nat. Med. 30, 382\u2013393 (2024).","journal-title":"Nat. Med."},{"key":"2300_CR72","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg7162","volume":"16","author":"S Seddighi","year":"2024","unstructured":"Seddighi, S. et al. Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS\/FTD. Sci. Transl. Med. 16, eadg7162 (2024).","journal-title":"Sci. Transl. Med."},{"key":"2300_CR73","doi-asserted-by":"publisher","unstructured":"Chizari, S., et al. TDP-43 pathology induces CD8+ T cell activation through cryptic epitope recognition. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.06.22.660773 (2025).","DOI":"10.1101\/2025.06.22.660773"},{"key":"2300_CR74","doi-asserted-by":"publisher","DOI":"10.1126\/science.adk3487","volume":"388","author":"ZA Ely","year":"2025","unstructured":"Ely, Z. A. et al. Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition. Science 388, eadk3487 (2025).","journal-title":"Science"},{"key":"2300_CR75","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41586-025-09588-6","volume":"647","author":"T Michaelis","year":"2025","unstructured":"Michaelis, T. et al. Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis. Nature 647, 970\u2013978 (2025).","journal-title":"Nature"},{"key":"2300_CR76","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1001\/jamaneurol.2023.2851","volume":"80","author":"A Genge","year":"2023","unstructured":"Genge, A. et al. Efficacy and safety of ravulizumab, a complement C5 inhibitor, in adults with amyotrophic lateral sclerosis: a randomized clinical trial. JAMA Neurol. 80, 1089\u20131097 (2023).","journal-title":"JAMA Neurol."},{"key":"2300_CR77","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.59058","volume":"8","author":"S Paganoni","year":"2025","unstructured":"Paganoni, S. et al. Efficacy and safety of zilucoplan in amyotrophic lateral sclerosis: a randomized clinical trial. JAMA Netw. Open 8, e2459058 (2025).","journal-title":"JAMA Netw. Open"},{"key":"2300_CR78","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.tips.2022.02.006","volume":"43","author":"WM Zelek","year":"2022","unstructured":"Zelek, W. M. & Morgan, B. P. Targeting complement in neurodegeneration: challenges, risks, and strategies. Trends Pharmacol. Sci. 43, 615\u2013628 (2022).","journal-title":"Trends Pharmacol. Sci."},{"key":"2300_CR79","doi-asserted-by":"publisher","DOI":"10.1111\/jns.70009","volume":"30","author":"QD Mohammad","year":"2025","unstructured":"Mohammad, Q. D. et al. Results from a phase 1 study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of ANX005, a C1q inhibitor, in patients with Guillain\u2013Barr\u00e9 syndrome. J. Peripher. Nerv. Syst. 30, e70009 (2025).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"2300_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043394","volume":"24","author":"U Meyer-Lindemann","year":"2023","unstructured":"Meyer-Lindemann, U., Moggio, A., Dutsch, A., Kessler, T. & Sager, H. B. The impact of exercise on immunity, metabolism, and atherosclerosis. Int. J. Mol. Sci. 24, 3394 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2300_CR81","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu, S. Z. et al. A single-cell and spatially resolved atlas of human breast cancers. Nat. Genet. 53, 1334\u20131347 (2021).","journal-title":"Nat. Genet."},{"key":"2300_CR82","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41586-022-05060-x","volume":"608","author":"C Kuppe","year":"2022","unstructured":"Kuppe, C. et al. Spatial multi-omic map of human myocardial infarction. Nature 608, 766\u2013777 (2022).","journal-title":"Nature"},{"key":"2300_CR83","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41586-023-06808-9","volume":"624","author":"M Zhang","year":"2023","unstructured":"Zhang, M. et al. Molecularly defined and spatially resolved cell atlas of the whole mouse brain. Nature 624, 343\u2013354 (2023).","journal-title":"Nature"},{"key":"2300_CR84","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/0008-5472.CAN-22-2682","volume":"83","author":"R Bassiouni","year":"2023","unstructured":"Bassiouni, R. et al. Spatial transcriptomic analysis of a diverse patient cohort reveals a conserved architecture in triple-negative breast cancer. Cancer Res. 83, 34\u201348 (2023).","journal-title":"Cancer Res."}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02300-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02300-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02300-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T19:01:58Z","timestamp":1783364518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02300-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":84,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2300"],"URL":"https:\/\/doi.org\/10.1038\/s41593-026-02300-5","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E. Kiskinis is an academic cofounder of NuCyRNA Therapeutics and SAB member of Axion Biosystems, ResQ Biotech, Synapticure, Live Like Lou Foundation and Packard Foundation. D.G. has been a consultant\/advisor for Merck related to anti-inflammatory therapy for ALS. Named companies and foundations were not involved in this project. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}